TCM
NVRO

Timpani Capital Management’s NEVRO CORP. NVRO Stock Holding History

Timpani Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-27,295
Closed -$2.37M – 113
2018
Q1 		$2.37M Buy
+27,295
New +$2.2M 0.83% 51
2017
Q2 		– Sell
-25,051
Closed -$2.35M – 111
2017
Q1 		$2.35M Sell
25,051
-1,333
-5% -$121K 0.94% 48
2016
Q4 		$1.92M Sell
26,384
-35,956
-58% -$3.08M 0.8% 54
2016
Q3 		$6.51M Buy
62,340
+26,959
+76% +$2.43M 2.59% 4
2016
Q2 		$2.61M Buy
35,381
+21,038
+147% +$1.43M 1.11% 38
2016
Q1 		$807K Buy
+14,343
New +$846K 0.34% 87

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Timpani Capital Management's NVRO Position: Q2 2018 in Review

Timpani Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2018, closing a stake of 27,295 shares — an estimated $2.37M sold.

Timpani Capital Management first reported a position in NVRO in Q1 2016 and held it in 6 quarters. The position peaked at $6.51M in Q3 2016. 192 funds tracked by Wall St. Rank hold NVRO as of Q2 2018.

  • Timpani Capital Management reported no remaining NEVRO CORP. position as of Q2 2018 after selling out during the quarter.
  • Timpani Capital Management sold 27,295 NEVRO CORP. shares in Q2 2018, an estimated $2.37M.
  • Timpani Capital Management first reported a position in NEVRO CORP. in Q1 2016 and held it in 6 quarters.
  • Timpani Capital Management's NEVRO CORP. position peaked at $6.51M in Q3 2016.
  • 192 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2018.

Based on Timpani Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.